Please login to be able to save your searches and receive alerts for new content matching your search criteria.
Intellectual property rights are essential in today's technology-driven age. A strong intellectual property protection strategy is crucial in the bioinformatics and biochips technology spaces as monetary and temporal resources are tremendous in finding a blockbuster drug or gene therapy, as well as in deploying advanced biosensor and other medical systems. Current problems and intellectual property practice in the genomic space are presented and analyzed. Various strategy and solutions are proposed to guide bioinformatic and biochip companies in forming an aggressive strategy to protect one's intellectual property and competitive positioning.
The article touches on the structural and functional genomics, tissue engineering, biochips and neurophysiology research in Shanghai.
Young Innovators under 35 - 2016 Asia's TR35 Innovators (EmTech Asia 2016)
New Biomedical R&D Centre Set Up by Lite-On Group in Singapore
The Philippines Initiates the World's First Public Dengue Vaccination Programme
This paper addresses challenging issues related to the integration of magnetoresistive (MR) sensors in applications such as magnetic field mapping, magnetic bead detection in microfluidic channels, or biochips. Although sharing the same technological principle for detection (magnetoresistance effect), each application has unique specifications in terms of noise, sensitivity, spatial resolution, electrical robustness or geometric constraints. These differences are of high impact for manufacturing, because some strategies used for sensor optimization compromise the freedom for device architecture.